These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23721635)

  • 1. Molecular genetic classification of difficult melanocytic tumors.
    Metzler G; Eigentler TK; Held L; Kind P; Hantschke M; Garbe C; Bauer J
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():11-8. PubMed ID: 23721635
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular biology methods to improve diagnosis and prognosis of melanocytic tumors.
    Wiesner T; Fried I; Cerroni L; Kutzner H
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():19-24. PubMed ID: 23721637
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutation analysis in malignant melanoma.
    Gaiser MR; Stadler R; Schirmacher P; Dietel M; Enk A
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():2-10. PubMed ID: 23721634
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular pathology diagnostics in cutaneous mesenchymal tumors.
    Kutzner H; Requena L; Palmedo G; Mentzel T
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():36-49. PubMed ID: 23721641
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular diagnostics in cutaneous lymphomas.
    Möbs M; Cerroni L; Flaig MJ; Lenze D; Hummel M; Assaf C
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():25-35. PubMed ID: 23721639
    [No Abstract]   [Full Text] [Related]  

  • 6. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
    de la Fouchardière A; Vergier B
    Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
    [No Abstract]   [Full Text] [Related]  

  • 7. [Molecular diagnosis of melanocytic tumors].
    Bauer J
    Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibroma-like spindle cell melanoma: CD34 fingerprint and CGH for diagnosis.
    Yeh I; Vemula SS; Mirza SA; McCalmont TH
    Am J Dermatopathol; 2012 Aug; 34(6):668-70. PubMed ID: 22456515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
    Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
    Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnostics in infectious skin diseases.
    Kempf W; Flaig MJ; Kutzner H
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():50-8. PubMed ID: 23721643
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular markers in melanoma.
    Kashani-Sabet M
    Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor.
    Pryor JG; Brown-Kipphut BA; Iqbal A; Scott GA
    Am J Dermatopathol; 2011 Dec; 33(8):780-5. PubMed ID: 21785329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular techniques for predicting behaviour in melanocytic neoplasms.
    Lee CY; Gerami P
    Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational profiling in melanocytic tumors: multiple somatic mutations and clinical implications.
    Richetta AG; Silvestri V; Giancristoforo S; Rizzolo P; D'Epiro S; Graziano V; Mattozzi C; Navazio AS; Falchetti M; Calvieri S; Ottini L
    Oncology; 2014; 86(2):104-8. PubMed ID: 24457427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
    Gerami P; Geraminegad P
    G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing.
    Lang UE; Yeh I; McCalmont TH
    Clin Lab Med; 2017 Sep; 37(3):473-484. PubMed ID: 28802496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
    Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
    Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic markers of prognosis in melanoma.
    Sigalotti L; Fratta E; Parisi G; Coral S; Maio M
    Methods Mol Biol; 2014; 1102():481-99. PubMed ID: 24258994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
    High WA
    Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.